This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Graft Versus Host Disease
and you are
over 18
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this study is to evaluate the presence and manifestations of ocular graft versus host disease in adults that had hematopoietic stem cell transplantation in the past 3 years at the sheba medical center, Israel. As well as correlate the degree of the presentation to the therapeutic protocol (chemotherapy and irradiation).
Tris trial is registered with FDA with number: NCT00912067. The sponsor of the trial is Sheba Medical Center and it is looking for 120 volunteers for the current phase.
Official trial title:
Ocular Graft Versus Host Disease After Hematopoietic Stem Cell Transplantation in Adults